Methods and materials for the detection of latent tuberculosis infection
AssigneeImperial College Innovations Limited
InventorsAjit Lalvani, Alice Halliday
Life of this patent
Estimating the term…
Loading patent…
AssigneeImperial College Innovations Limited
InventorsAjit Lalvani, Alice Halliday
Estimating the term…
There are provided methods of determining the latent tuberculosis (TB) infection status in an individual comprising: (i) providing a sample comprising T-cells; (ii) exposing, the sample of (i) to one or more TB antigens; (iii) identifying T-cells in the sample that are CD4 positive and secrete IFN-γ in response to TB antigens; (iv) identifying those cells of (iii) which are also HLA-DR positive; and optionally (v) calculating the cells identified in (iv) as a percentage of those identified in (iii); wherein the identification of cells in (iv) and/or the percentage of cells calculated in (v) correlates to latent TB infection status of the individual, and wherein steps (iii) and (iv) can be carried out either sequentially or simultaneously. There are also provided compositions and kits for use in such methods.
A method of determining the latent tuberculosis (TB) infection status in an individual comprising:
The method of any previous claim wherein the latent TB infection status determined by the method corresponds to the amount of time elapsed since the individual was originally infected with TB.
The method of any previous claim wherein the cells identified in step (iii) are additionally CD3 positive.
The method of any previous claim wherein the cells identified in step (iii) are additionally CD8 negative.
The method of any previous claim wherein the T-cells identified in step (iii) are identified as live T-cells, preferably by use of a dead cell marker.
The method of any previous claim wherein an additional step (ii-a) is performed between steps (ii) and (iii) to block the release of cytokines, preferably by adding a golgi-inhibitor.
The method of any previous claim wherein the sample is a blood sample (preferably a PBMC sample), a bronochoalveolar lavage (BAL) sample or a cerebral spinal (CBF) sample.
The method of any previous claim wherein steps (iii) and/or (iv) are performed by multi-parameter flow cytometry.
The method of any previous claim wherein an additional step is first performed in order to determine that the sample is obtained from an individual infected with latent TB.
A composition comprising a plurality of antibodies or antigen-binding fragments thereof that binds to each of CD4, IFN-γ and HLA-DR and wherein the plurality comprises antibodies or antigen-binding fragments thereof that are individually specific for each of CD4, IFN-γ and HLA-DR.
A kit for determining tuberculosis (TB) infection status in an individual comprising:
A method, composition, kit or use substantially as described herein with reference to the Examples and Figures.
Dependencies are inferred from the claim text.